Dyve Biosciences has developed a breakthrough topical skin penetration technology. The innovative approach enables drugs to be transported from the surface of the skin into the blood with needle-like speed and pill-like efficiency. Dyve has advanced clinical programs in gout and melasma and a robust pre-clinical and clinical data set across a broad set of molecules. At Dyve, the focus is on robust science, compelling data, and delivering positive patient outcomes.
